Source: Clinical Laboratory News
Sciex Diagnostics, a life sciences company specializing in mass spectrometry instruments, has obtained approval from the China Food and Drug Administration for its AB Sciex Triple Quad 4500MD LC-MS/MS system. The system is composed of a triple quadrupole mass spectrometer (MS), a liquid chromatography (LC) system, and AnalystMD, CliquidMD, and MultiQuantMD analysis software. Sciex designed the instrument for use with various reagents to analyze diagnostic indicators such as amino acids and hormones, as well as to examine therapeutic monitoring compounds. The system features Sciex’s proprietary technology that is designed to maximize uptime in clinical laboratories and support high-throughput operations, enabling labs to perform multiple assays and quantify several compounds in a single run.